In addition, ketamine elevates extracellular glutamate levels in the PFC and HIP, while enhancing synaptic connectivity via activation of the BDNF-TrkB pathway, thereby mitigating the degenerative changes linked to depression [133,134]. This evidence concerns the gene BDNF and depressive symptom measurement.